Новизна в диагностике предраковыx поражений желудка.
DOI:
https://doi.org/10.52692/1857-0011.2021.3-71.34Ключевые слова:
хронический атрофический гастрит, кишечная метаплазия желудка, дисплазия эпителия слизистой оболочки желудка, эндоскопическое исследование, морфологическое исследование, серологическое исследование, Helicobacter pyloriАннотация
Введение: Выявление и тщательный мониторинг пациентов с предраковыми поражениями - хроническим атрофическим гастритом (ХАГ), кишечной метаплазией желудка (КМЗ) и эпителиальной дисплазией слизистой оболочки желудка (ДСОЖ) является приоритетом для повышения раннего выявления и, косвенно, снижения смертности и смертности рак желудка (РЖ). Целью данного исследования является разработка нарративного синтеза современных исследований методов диагностики ХАГ. Материалы и методы. В течение 2000-2020 годов проводилось изучение подходящих исследований в базах данных PubMed, Hinari, SpringerLink и Scopus (Elsevier). Результаты: Из 575--ти статей, посвященных теме предраковых поражений, 59 статей были квалифицированным представителем материалов, опубликованных по теме данной сводной статьи. Выводы: существует два основных методологических подхода к оценке GCA: неинвазивное серологическое исследование с использованием маркеров функции желудка и инвазивное исследование, которое требует гистологического анализа биоптатов, взятых во время эндоскопии верхних отделов пищеварения, последнее является «золотым стандартом» для диагностики.Библиографические ссылки
Pimentel-Nunes P., Libânio D., Marcos-Pinto R.,Areia M., Leja M., Esposito G. et al. Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG), European Society of Pathology (ESP), and Sociedade Portuguesa de Endoscopia Digestiva (SPED) guideline update 2019. Endoscopy. 2019; 51(4): 365-388.
Valdes-Socin H., Leclercq P., Polus M., Rohmer V., Beckers A., Louis E. Chronic autoimmune gastritis: a multidisciplinary management. Rev Med Liege. 2019; 74(11): 598-605.
Koulis A., Buckle A., Boussioutas A. Premalignant lesions and gastric cancer: Current understanding. World J Gastrointest Oncol. 2019; 11(9): 665-678.
Syrjänen K., Eskelinen M., Peetsalu A., Sillakivi T., Sipponen P., Härkönen M. et al. GastroPanel® Biomarker Assay: The Most Comprehensive Test for Helicobacter pylori Infection and Its Clinical Sequelae. A Critical Review. Anticancer Res. 2019; 39(3):1091-1104.
Banks M., Graham D., Jansen M., Gotoda T., Coda S.,di Pietro M. et al. British Society of Gastroenterology guidelines on the diagnosis and management of patients at risk of gastric adenocarcinoma. Gut. 2019; 68(9): 1545-1575.
Bang C.S., Lee J.J., Baik G.H. Diagnostic performance of serum pepsinogen assay for the prediction of atrophic gastritis and gastric neoplasms: Protocol for a systematic review and meta-analysis. Medicine (Baltimore). 2019; 98(4): e14240.
Bang C.S., Lee J.J., Baik G.H. Prediction of Chronic Atrophic Gastritis and Gastric Neoplasms by Serum Pepsinogen Assay: A Systematic Review and Meta-Analysis ofDiagnostic Test Accuracy. J Clin Med. 2019; 8(5): E657.
Rodriguez-Castro K., Franceschi M., Noto A., Miraglia C., Nouvenne A., Leandro G. et al. Clinical manifestations of chronic atrophic gastritis. Acta Biomed. 2018; 89(8-S): 88-92.
Lahner E., Zagari R., Zullo A., Di Sabatino A., Meggio A., Cesaro P. et al. Chronic atrophic gastritis: Natural history, diagnosis and therapeutic management. A position paper by the Italian Society of Hospital Gastroenterologists and Digestive Endoscopists [AIGO], the Italian Society of Digestive Endoscopy [SIED], the Italian Society of Gastroenterology [SIGE], and the Italian Society of Internal Medicine [SIMI]. Dig Liver Dis. 2019; 51(12): 1621-1632.
Su W., Zhou B., Qin G., Chen Z., Geng X., Chen X. et al. Low PG I/II ratio as a marker of atrophic gastritis: Association with nutritional and metabolic status in healthy people. Medicine (Baltimore). 2018; 97(20): e10820.
Zhang Y., Li F., Yuan F., Zhang K., Huo L., Dong Z. et al. Diagnosing chronic atrophic gastritis by gastroscopy using artificial intelligence. Dig Liver Dis. 2020 [Epub ahead of print].
Jin E., Chung S., Lim J., Chung G., Lee C., Yang J. et al. Training Effect on the Inter-observer Agreement in Endoscopic Diagnosis and Grading of Atrophic Gastritis according to Level of Endoscopic Experience. J Korean Med Sci. 2018; 33(15): e117.
Korstanje A., den Hartog G., Biemond I., Lamers C. Chapter III. The serological gastric biopsy: a non-endoscopical diagnostic approach in management of the dyspeptic patient. Scand J Gastroenterol. 2002; 37 Suppl. 236: 37-45 (modified version).
Mescoli C., Gallo Lopez A., Taxa Rojas L., Jove Oblitas W., Fassan M., Rugge M. Gastritis staging as a clinical priority. Eur J Gastroenterol Hepatol. 2018; 30(2): 125-129.
Cha J.H., Jang J.S. Clinical correlation between serum pepsinogen level and gastric atrophy in gastric neoplasm. Korean J Intern Med. 2018 [Epub ahead of print]
Eshmuratov A., Nah J., Kim N., Lee H., Lee H., Lee B. et al. The correlation of endoscopic and histological diagnosis of gastric atrophy. Dig Dis Sci. 2010; 55(5):1364-1375.
Lahner E., Esposito G., Zullo A., Hassan C., Carabotti M., Galli G. et al. Gastric precancerous conditions and Helicobacter pylori infection in dyspeptic patients with or without endoscopic lesions. Scand J Gastroenterol. 2016; 51(11): 1294-1298.
Huang R.J., Choi A.Y., Truong C.D., Yeh M.M., Hwang J.H. Diagnosis and Management of Gastric Intestinal Metaplasia: Current Status and Future Directions. Gut Liver. 2019; 13(6): 596-603.
Panteris V., Nikolopoulou S., Lountou A., Triantafillidis J. Diagnostic capabilities of high-definition white light endoscopy for the diagnosis of gastric intestinal metaplasia and correlation with histologic and clinical data. Eur J Gastroenterol Hepatol. 2014; 26(6): 594-601.
Pimentel-Nunes P., Libânio D., Lage J., Abrantes D., Coimbra M., Esposito G. et al. A multicenter prospective study of the real-time use of narrow-band imaging in the diagnosis of premalignant gastric conditions and lesions. Endoscopy. 2016; 48(8): 723-730.
Ang T., Pittayanon R., Lau J., Rerknimitr R., Ho S., Singh R. et al. A multicenter randomized comparison between high-definition white light endoscopy and narrow band imaging for detection of gastric lesions. Eur J Gastroenterol Hepatol. 2015; 27(12): 1473-1478.
Anagnostopoulos G., Yao K., Kaye P., Fogden E., Fortun P., Shonde A. et al. High-resolution magnification endoscopy can reliably identify normal gastric mucosa, Helicobacter pylori-associated gastritis, and gastric atrophy. Endoscopy. 2007; 39(3): 202-207.
Tongtawee T., Kaewpitoon S., Kaewpitoon N., Dechsukhum C., Loyd R., Matrakool L. Correlation between Gastric Mucosal Morphologic Patterns and Histopathological Severity of Helicobacter pylori Associated Gastritis Using Conventional Narrow Band Imaging Gastroscopy. Biomed Res Int. 2015; 2015: 808505.
White J., Sami S., Reddiar D., Mannath J., Ortiz-Fernández-Sordo J., Beg S. et al. Narrow band imaging and serology in the assessment of premalignant gastric pathology. Scand J Gastroenterol. 2018; 53(12): 1611-1618.
Ang T., Fock K., Teo E., Tan J., Poh C., Ong J. et al. The diagnostic utility of narrow band imaging magnifying endoscopy in clinical practice in a population with intermediate gastric cancer risk. Eur J Gastroenterol Hepatol. 2012; 24(4): 362-367.
Uedo N., Ishihara R., Iishi H., Yamamoto S., Yamamoto S., Yamada T. et al. A new method of diagnosing gastric intestinal metaplasia: narrow-band imaging with magnifying endoscopy. Endoscopy. 2006; 38(8): 819-824.
Buxbaum J., Hormozdi D., Dinis-Ribeiro M., Lane C., Dias-Silva D., Sahakian A. et al. Narrow-band imaging versus white light versus mapping biopsy for gastric intestinal metaplasia: a prospective blinded trial. Gastrointest Endosc. 2017; 86(5): 857-865.
Syrjänen K. Serum Biomarker Panel (GastroPanel®) and Slow-Release L-cysteine (Acetium® Capsule): Rationale for the Primary Prevention of Gastric Cancer. EC Gastroenterology and Digestive System. 2017; 3(6): 172-192.
Wang X., Ling L., Li S., Qin G., Cui W., Li X. et al. The Diagnostic Value of Gastrin-17 Detection in Atrophic Gastritis: A Meta-Analysis. Medicine (Baltimore). 2016; 95(18): e3599.
Dong Z., Zhang X., Chen X., Zhang J. Significance of Serological Gastric Biopsy in Different Gastric Mucosal Lesions: an Observational Study. Clin Lab. 2019; 65(12) [Epub ahead of print].
Syrjänen K. Serological Biomarker Panel (Gastro-Panel®): A Test for Non-Invasive Diagnosis of Dyspeptic Symptoms and for Comprehensive Detection of Helicobacter pylori Infection. Biomark J. 2017; 3: 1.
Loor A., Dumitraşcu D. Helicobacter pylori Infection, Gastric Cancer and Gastropanel. Rom J Intern Med. 2016; 54(3): 151-156.
Syrjänen K., Eronen K. Serological Testing in Management of Dyspeptic Patients and in Screening of Gastric Cancer Risks. J Gastrointest Disord Liver Func. 2016; 2(2): 84-88.
Bang C.S., Lee J.J., Baik G.H. Prediction of Chronic Atrophic Gastritis and Gastric Neoplasms by Serum Pepsinogen Assay: A Systematic Review and Meta- Analysis of Diagnostic Test Accuracy. J Clin Med. 2019; 8(5): E657.
.Giroux V., Rustgi A. Metaplasia: tissue injury adaptation and a precursor to the dysplasia-cancer sequence. Nat Rev Cancer. 2017; 17(10): 594-604.
Leja M., Kupcinskas L., Funka K., Sudraba A., Jonaitis L., Ivanauskas A. et al. Value of gastrin-17 in detecting antral atrophy. Adv Med Sci. 2011; 56(2): 145-150
McNicholl A., Forné M., Barrio J., De la Coba C., González B., Rivera R. et al. Accuracy of GastroPanel for the diagnosis of atrophic gastritis. Eur J Gastroenterol Hepatol. 2014; 26(9): 941-948.
Huang Y., Yu J., Kang W., Ma Z., Ye X., Tian S. et al. Significance of Serum Pepsinogens as a Biomarker for Gastric Cancer and Atrophic Gastritis Screening: A Systematic Review and Meta-Analysis. PLoS One. 2015; 10(11): e0142080.
Sugano K., Tack J., Kuipers E., Graham D., El-Omar E., Miura S. et al. Kyoto global consensus report on Helicobacter pylori gastritis. Gut. 2015; 64(9): 1353-1367.
Mardh E., Mardh S., Mardh B., Borch K. Diagnosis of gastritis by means of a combination of serologicalanalyses. Clin Chim Acta. 2002; 320(1-2): 17-27.
Weck M., Brenner H. Association of Helicobacter pylori infection with chronic atrophic gastritis: Meta-analyses according to type of disease definition. Int J Cancer.2008; 123(4): 874-881.
Broutet N., Plebani M. Sakarovitch C. Sipponen P. Mégraud F. Pepsinogen A, pepsinogen C, and gastrin as markers of atrophic chronic gastritis in European dyspeptics. Br J Cancer. 2003; 88(8): 1239-1247.
Loong T., Soon N., Nik Mahmud N., Naidu J., Rani R., Abdul Hamid N. et al. Serum pepsinogen and gastrin- 17 as potential biomarkers for pre-malignant lesions in the gastric corpus. Biomed Rep. 2017; 7(5): 460-468.
Mansour-Ghanaei F., Joukar F., Baghaee M., Sepehrimanesh M., Hojati A. Only serum pepsinogen I and pepsinogen I/II ratio are specific and sensitive biomarkers for screening of gastric cancer. Biomol Concepts. 2019; 10(1): 82-90.
Noah D., Assoumou M., Bagnaka S., Ngaba G., Alonge I., Paloheimo L. et al. Assessing GastroPanel serum markers as a non-invasive method for the diagnosis of atrophic gastritis and Helicobacter pylori infection. Open J Gastroenterol. 2012; 2(3): 113-118.
Syrjänen K. A Panel of Serum Biomarkers (GastroPanel ®) in Non-invasive Diagnosis of Atrophic Gastritis.Systematic Review and Meta-analysis. Anticancer Res.2016; 36(10): 5133-5144.
Brenner H., Rothenbacher D., Weck M. Epidemiologic findings on serologically defined chronic atrophic gastritis strongly depend on the choice of the cutoff-value. Int J Cancer. 2007; 121(12): 2782-2786.
Pasechnikov V.D., Chukov S.Z., Kotelevets S.M., Mostovov A.N., Mernova V.P., Polyakova M.B. Invasive and non-invasive diagnosis of Helicobacter pylori-associated atrophic gastritis: a comparative study. Scand J Gastroenterol. 2005; 40(3): 297-301.
Korstanje A., den Hartog G., Biemond I., Lamers C. The serological gastric biopsy: a non-endoscopical diagnostic approach in management of the dyspeptic patient: significance for primary care based on a survey of the literature. Scand J Gastroenterol Suppl. 2002; 37 Suppl 236: 22-26.
Lahner E., Carabotti M., Annibale B. Atrophic body gastritis: clinical presentation, diagnosis, and outcome. EMJ Gastroenterol. 2017; 6(1): 75-82.
Zagari R., Rabitti S., Greenwood D., Eusebi L., Vestito A., Bazzoli F. Systematic review with meta-analysis: diagnostic performance of the combination of pepsinogen, gastrin-17 and anti-Helicobacter pylori antibodies serum assays for the diagnosis of atrophic gastritis. Aliment Pharmacol Ther. 2017; 46(7): 657-667.
Iijima K., Abe Y., Kikuchi R., Koike T., Ohara S., Sipponen P. et al. Serum biomarker tests are useful in delineating between patients with gastric atrophy and normal, healthy stomach. World J Gastroenterol. 2009; 15(7): 853-859.
McNicholl A., Forné M., Barrio J., De la Coba C., González B., Rivera R. et al. Accuracy of GastroPanel for the diagnosis of atrophic gastritis. Eur J Gastroenterol Hepatol. 2014; 26(9): 941-948.
Lee J., Kim N., Lee H., Oh J., Kwon Y., Choi Y. et al. Correlations among endoscopic, histologic and serologic diagnoses for the assessment of atrophic gastritis. J Cancer Prev. 2014; 19(1): 47-55.
Al-Nuaimya W.M., Faisalb H.M. Endoscopical and Histopathological Interpretation of Gastritis in Nineveh Province. Ann Coll Med Mosul 2019; 41(1): 28-35.
Lee S.P., Lee S.Y., Kim J.H., Sung I.K., Park H.S., Shim C.S. Link between Serum Pepsinogen Concentrations and Upper Gastrointestinal Endoscopic Findings. J Korean Med Sci. 2017; 32(5): 796-802.
Wang X., Lu B., Meng L., Fan Y., Zhang S., Li M. The correlation between histological gastritis staging - ‚OLGA/OLGIM’ and serum pepsinogen test in assessment of gastric atrophy/intestinal metaplasia in China. Scand J Gastroenterol. 2017; 52(8): 822-827.
Rugge M., Genta R., Graham D., Di Mario F., Vaz Coelho L., Kim N. et al. Chronicles of a cancer foretold: 35 years of gastric cancer risk assessment. Gut. 2016; 65(5): 721-725.
Daugule I., Sudraba A., Chiu H., Funka K., Ivanauskas A., Janciauskas D. et al. Gastric plasma biomarkers and Operative Link for Gastritis Assessment gastritis stage. Eur J Gastroenterol Hepatol. 2011; 23(4): 302-307.
Загрузки
Опубликован
Выпуск
Раздел
Лицензия
Copyright (c) 2022 Вестник Академии Наук Молдовы. Медицина
Это произведение доступно по лицензии Creative Commons «Attribution» («Атрибуция») 4.0 Всемирная.
